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Abstract
Nicotinic	acetylcholine	(ACh)	receptors	are	members	of	the	Cys-loop	family	of	transmitter-gated	ion
channels	that	includes	the	GABAA,	strychnine-sensitive	glycine	and	5-HT3	receptors	[215,	3,	159,
225,	259].	All	nicotinic	receptors	are	pentamers	in	which	each	of	the	five	subunits	contains	4	TM
domains.	Genes	encoding	a	total	of	17	subunits	(α1-10,	β1-4,	γ,	δ	and	ε)	have	been	identified	[120].
All	subunits	with	the	exception	of	α8	(present	in	avian	species)	have	been	identified	in	mammals.	All
α	subunits	possess	two	tandem	cysteine	residues	near	to	the	site	involved	in	acetylcholine	binding,
and	subunits	not	named	α	lack	these	residues	[159].	The	orthosteric	ligand	binding	site	is	formed	by
residues	within	at	least	three	peptide	domains	on	the	α	subunit	(principal	component),	and	three	on
the	adjacent	subunit	(complementary	component).	Nicotinic	ACh	receptors	contain	several	allosteric
modulatory	sites.	One	such	site,	for	positive	allosteric	modulators	(PAMs)	and	allosteric	agonists,	has
been	proposed	to	reside	within	an	intrasubunit	cavity	between	the	4	TM	domains	[264,	87];	see	also
[106]).	The	high	resolution	crystal	structure	of	the	molluscan	ACh	binding	protein,	a	structural
homologue	of	the	extracellular	binding	domain	of	a	nicotinic	receptor	pentamer,	in	complex	with
several	nicotinic	receptor	ligands	(e.g.[35])	and	the	crystal	structure	of	the	extracellular	domain	of
the	α1	subunit	bound	to	α-bungarotoxin	at	1.94Â	resolution	[55],	has	revealed	the	orthosteric	binding
site	in	detail	(reviewed	in	[215,	120,	39,	198]).	Nicotinic	receptors	at	the	somatic	neuromuscular
junction	of	adult	animals	have	the	stoichiometry	(α1)2β1δε,	whereas	an	extrajunctional	(α1)2β1γδ
receptor	predominates	in	embryonic	and	denervated	skeletal	muscle	and	other	pathological	states.
Other	nicotinic	receptors	are	assembled	as	combinations	of	α(2-6)	and	β(2-4)	subunits.	For	α2,	α3,	α4
and	β2	and	β4	subunits,	pairwise	combinations	of	α	and	β	(e.g.	α3β4	and	α4β2)	are	sufficient	to	form
a	functional	receptor	in	vitro,	but	far	more	complex	isoforms	may	exist	in	vivo	(reviewed	in	[96,	93,
159]).	There	is	strong	evidence	that	the	pairwise	assembly	of	some	α	and	β	subunits	can	occur	with
variable	stoichiometry	[e.g.	(α4)2(β2)2	or	(α4)3(β2)2]	which	influences	the	biophysical	and
pharmacological	properties	of	the	receptor	[159].	α5	and	β3	subunits	lack	function	when	expressed
alone,	or	pairwise,	but	participate	in	the	formation	of	functional	hetero-oligomeric	receptors	when
expressed	as	a	third	subunit	with	another	α	and	β	pair	[e.g.	α4α5αβ2,	α4αβ2β3,	α5α6β2,	see	[159]	for
further	examples].	The	α6	subunit	can	form	a	functional	receptor	when	co-expressed	with	β4	in	vitro,
but	more	efficient	expression	ensues	from	incorporation	of	a	third	partner,	such	as	β3	[263].	The	α7,
α8,	and	α9	subunits	form	functional	homo-oligomers,	but	can	also	combine	with	a	second	subunit	to
constitute	a	hetero-oligomeric	assembly	(e.g.	α7β2	and	α9α10).	For	functional	expression	of	the	α10
subunit,	co-assembly	with	α9	is	necessary.	The	latter,	along	with	the	α10	subunit,	appears	to	be
largely	confined	to	cochlear	and	vestibular	hair	cells.	Comprehensive	listings	of	nicotinic	receptor
subunit	combinations	identified	from	recombinant	expression	systems,	or	in	vivo,	are	given	in	[159].
In	addition,	numerous	proteins	interact	with	nicotinic	ACh	receptors	modifying	their	assembly,
trafficking	to	and	from	the	cell	surface,	and	activation	by	ACh	(reviewed	by	[158,	9,	118]).
The	nicotinic	receptor	Subcommittee	of	NC-IUPHAR	has	recommended	a	nomenclature	and
classification	scheme	for	nicotinic	acetylcholine	(nACh)	receptors	based	on	the	subunit	composition
of	known,	naturally-	and/or	heterologously-expressed	nACh	receptor	subtypes	[143].	Headings	for
this	table	reflect	abbreviations	designating	nACh	receptor	subtypes	based	on	the	predominant	α
subunit	contained	in	that	receptor	subtype.	An	asterisk	following	the	indicated	α	subunit	denotes	that
other	subunits	are	known	to,	or	may,	assemble	with	the	indicated	α	subunit	to	form	the	designated
nACh	receptor	subtype(s).	Where	subunit	stoichiometries	within	a	specific	nACh	receptor	subtype
are	known,	numbers	of	a	particular	subunit	larger	than	1	are	indicated	by	a	subscript	following	the
subunit	(enclosed	in	parentheses-	see	also	[46]).
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